

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 8.29604823 |
| 2 | regulation of protein activation cascade (GO:2000257) | 8.11071352 |
| 3 | complement activation, alternative pathway (GO:0006957) | 7.70135113 |
| 4 | regulation of complement activation (GO:0030449) | 7.45363084 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.42156724 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.10770665 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.10770665 |
| 8 | drug catabolic process (GO:0042737) | 7.03119295 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 7.03055182 |
| 10 | urea metabolic process (GO:0019627) | 6.73902458 |
| 11 | protein carboxylation (GO:0018214) | 6.66176734 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.66176734 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.50903288 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.50903288 |
| 15 | phenylpropanoid metabolic process (GO:0009698) | 6.33175943 |
| 16 | blood coagulation, intrinsic pathway (GO:0007597) | 6.18677658 |
| 17 | bile acid biosynthetic process (GO:0006699) | 6.17198597 |
| 18 | urea cycle (GO:0000050) | 6.15173557 |
| 19 | fibrinolysis (GO:0042730) | 6.15058507 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 6.12202581 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 6.09534411 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 6.00450223 |
| 23 | exogenous drug catabolic process (GO:0042738) | 5.60215803 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.47439261 |
| 25 | negative regulation of protein activation cascade (GO:2000258) | 5.46563155 |
| 26 | cellular glucuronidation (GO:0052695) | 5.42606070 |
| 27 | oxidative demethylation (GO:0070989) | 5.41041046 |
| 28 | acute-phase response (GO:0006953) | 5.40682460 |
| 29 | drug metabolic process (GO:0017144) | 5.39957575 |
| 30 | bile acid metabolic process (GO:0008206) | 5.39679716 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.38869565 |
| 32 | uronic acid metabolic process (GO:0006063) | 5.22557456 |
| 33 | glucuronate metabolic process (GO:0019585) | 5.22557456 |
| 34 | ethanol oxidation (GO:0006069) | 5.03163359 |
| 35 | omega-hydroxylase P450 pathway (GO:0097267) | 5.02278299 |
| 36 | protein activation cascade (GO:0072376) | 5.00154269 |
| 37 | negative regulation of complement activation (GO:0045916) | 4.91770072 |
| 38 | regulation of humoral immune response (GO:0002920) | 4.83305042 |
| 39 | triglyceride homeostasis (GO:0070328) | 4.81060685 |
| 40 | acylglycerol homeostasis (GO:0055090) | 4.81060685 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 4.76711996 |
| 42 | glycine metabolic process (GO:0006544) | 4.73808781 |
| 43 | complement activation (GO:0006956) | 4.72349212 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.71253334 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.71253334 |
| 46 | alkaloid metabolic process (GO:0009820) | 4.70718343 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.69844313 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.69844313 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.61942996 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.60434654 |
| 51 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.60434654 |
| 52 | complement activation, classical pathway (GO:0006958) | 4.54340414 |
| 53 | arginine metabolic process (GO:0006525) | 4.52563915 |
| 54 | polyketide metabolic process (GO:0030638) | 4.48146675 |
| 55 | doxorubicin metabolic process (GO:0044598) | 4.48146675 |
| 56 | daunorubicin metabolic process (GO:0044597) | 4.48146675 |
| 57 | ethanol metabolic process (GO:0006067) | 4.47866478 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 4.43509577 |
| 59 | macromolecular complex remodeling (GO:0034367) | 4.43509577 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43509577 |
| 61 | cysteine metabolic process (GO:0006534) | 4.42109705 |
| 62 | negative regulation of wound healing (GO:0061045) | 4.38474166 |
| 63 | acute inflammatory response (GO:0002526) | 4.37114712 |
| 64 | phospholipid efflux (GO:0033700) | 4.32283004 |
| 65 | negative regulation of humoral immune response (GO:0002921) | 4.31981915 |
| 66 | regulation of cholesterol esterification (GO:0010872) | 4.31782775 |
| 67 | negative regulation of coagulation (GO:0050819) | 4.30929812 |
| 68 | hormone catabolic process (GO:0042447) | 4.23248215 |
| 69 | primary alcohol catabolic process (GO:0034310) | 4.19324170 |
| 70 | regulation of bile acid biosynthetic process (GO:0070857) | 4.19033712 |
| 71 | bile acid and bile salt transport (GO:0015721) | 4.18396300 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 4.15628326 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 4.11929242 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 4.05393521 |
| 75 | steroid catabolic process (GO:0006706) | 4.02565809 |
| 76 | tyrosine metabolic process (GO:0006570) | 4.00664094 |
| 77 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.95325124 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 3.89275414 |
| 79 | positive regulation of hemostasis (GO:1900048) | 3.89275414 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89033223 |
| 81 | regulation of lipoprotein particle clearance (GO:0010984) | 3.87269014 |
| 82 | negative regulation of lipase activity (GO:0060192) | 3.85925095 |
| 83 | aldehyde catabolic process (GO:0046185) | 3.81376260 |
| 84 | cholesterol efflux (GO:0033344) | 3.76532916 |
| 85 | retinal metabolic process (GO:0042574) | 3.68209504 |
| 86 | cytolysis (GO:0019835) | 3.67927657 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.67662726 |
| 88 | positive regulation of coagulation (GO:0050820) | 3.61462696 |
| 89 | regulation of acute inflammatory response (GO:0002673) | 3.58954498 |
| 90 | arginine catabolic process (GO:0006527) | 3.57615999 |
| 91 | reverse cholesterol transport (GO:0043691) | 3.57605888 |
| 92 | xenobiotic metabolic process (GO:0006805) | 3.57010129 |
| 93 | heme transport (GO:0015886) | 3.55649360 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.52958136 |
| 95 | opsonization (GO:0008228) | 3.52170267 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50314418 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.50245072 |
| 98 | alpha-amino acid catabolic process (GO:1901606) | 3.48924740 |
| 99 | carnitine metabolic process (GO:0009437) | 3.46105589 |
| 100 | flavonoid metabolic process (GO:0009812) | 3.45204979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.66007282 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.82774511 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27072992 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.09989840 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01719866 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81906412 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.65832791 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84819907 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81780584 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41065441 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95707154 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.88293416 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.84770053 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80771308 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61192257 |
| 16 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55162469 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48492852 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44651911 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37601688 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37243981 |
| 21 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36891392 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32849844 |
| 23 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26022784 |
| 24 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23691614 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20583728 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19763249 |
| 27 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17926615 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.14897353 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14545726 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12785944 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11167594 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08363981 |
| 33 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05945085 |
| 34 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05834889 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04247263 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02896806 |
| 37 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00690750 |
| 38 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00447201 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.98303396 |
| 40 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97333709 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97129389 |
| 42 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.97106711 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96608984 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 0.95502349 |
| 45 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94837338 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94543707 |
| 47 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92414287 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91455523 |
| 49 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.90039069 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89807485 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89502553 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89033167 |
| 53 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.87976761 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86894864 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86405811 |
| 56 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86015124 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85942069 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85603146 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85399990 |
| 60 | NFYA_21822215_ChIP-Seq_K562_Human | 0.84741874 |
| 61 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.83941821 |
| 62 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.82554487 |
| 63 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82313991 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81853019 |
| 65 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.81737479 |
| 66 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.81688211 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81587801 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81138899 |
| 69 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.81137978 |
| 70 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.80785282 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80162384 |
| 72 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79339574 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.78959525 |
| 74 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.78888095 |
| 75 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.78707349 |
| 76 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.77619177 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.75858726 |
| 78 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.75232917 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73978309 |
| 80 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.73583679 |
| 81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.73233680 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.72706131 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71697068 |
| 84 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.71543527 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71498875 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71002707 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69896634 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.68578301 |
| 89 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.68048499 |
| 90 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.67296240 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65986886 |
| 92 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65665213 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65660000 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.65631628 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.65121272 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.64124669 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.63785843 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63670543 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.63330643 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.63313969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.19609725 |
| 2 | MP0005360_urolithiasis | 6.73257943 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16889795 |
| 4 | MP0005365_abnormal_bile_salt | 5.64346829 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.38517668 |
| 6 | MP0003195_calcinosis | 5.09224727 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 5.00860908 |
| 8 | MP0003868_abnormal_feces_composition | 4.57690488 |
| 9 | MP0009697_abnormal_copulation | 3.70434057 |
| 10 | MP0003252_abnormal_bile_duct | 3.40877614 |
| 11 | MP0001666_abnormal_nutrient_absorption | 3.13291692 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.88883770 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.74459891 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.45943005 |
| 15 | MP0009840_abnormal_foam_cell | 2.24514132 |
| 16 | MP0001764_abnormal_homeostasis | 2.11735014 |
| 17 | MP0005332_abnormal_amino_acid | 2.09067976 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.08444868 |
| 19 | MP0000609_abnormal_liver_physiology | 1.70709689 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.68775752 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.63281782 |
| 22 | MP0003186_abnormal_redox_activity | 1.36004755 |
| 23 | MP0002132_abnormal_respiratory_system | 1.28690296 |
| 24 | MP0005408_hypopigmentation | 1.17579573 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.06570987 |
| 26 | MP0000604_amyloidosis | 1.04430304 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00437023 |
| 28 | MP0009643_abnormal_urine_homeostasis | 0.99527239 |
| 29 | MP0005376_homeostasis/metabolism_phenot | 0.97603644 |
| 30 | MP0000598_abnormal_liver_morphology | 0.96731383 |
| 31 | MP0005187_abnormal_penis_morphology | 0.96510769 |
| 32 | MP0002090_abnormal_vision | 0.95913470 |
| 33 | MP0010386_abnormal_urinary_bladder | 0.94383893 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 0.89440834 |
| 35 | MP0009763_increased_sensitivity_to | 0.88183705 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.85145468 |
| 37 | MP0009764_decreased_sensitivity_to | 0.84125261 |
| 38 | MP0005395_other_phenotype | 0.82891434 |
| 39 | MP0002971_abnormal_brown_adipose | 0.82799576 |
| 40 | MP0001915_intracranial_hemorrhage | 0.82662204 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 0.80258978 |
| 42 | MP0003011_delayed_dark_adaptation | 0.78743479 |
| 43 | MP0002168_other_aberrant_phenotype | 0.78734750 |
| 44 | MP0008469_abnormal_protein_level | 0.77721882 |
| 45 | MP0001661_extended_life_span | 0.77183281 |
| 46 | MP0005058_abnormal_lysosome_morphology | 0.76397234 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.75183190 |
| 48 | MP0005464_abnormal_platelet_physiology | 0.70076617 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 0.68889415 |
| 50 | MP0005535_abnormal_body_temperature | 0.65360533 |
| 51 | MP0005164_abnormal_response_to | 0.63409251 |
| 52 | MP0008874_decreased_physiological_sensi | 0.62124847 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 0.61913023 |
| 54 | MP0009785_altered_susceptibility_to | 0.60679119 |
| 55 | MP0000249_abnormal_blood_vessel | 0.57223908 |
| 56 | MP0003638_abnormal_response/metabolism_ | 0.57167130 |
| 57 | MP0008872_abnormal_physiological_respon | 0.55895592 |
| 58 | MP0003075_altered_response_to | 0.53154168 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.53017566 |
| 60 | MP0005451_abnormal_body_composition | 0.50785734 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 0.50073622 |
| 62 | MP0009053_abnormal_anal_canal | 0.48640606 |
| 63 | MP0003690_abnormal_glial_cell | 0.48535681 |
| 64 | MP0005083_abnormal_biliary_tract | 0.48243922 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 0.47664855 |
| 66 | MP0005166_decreased_susceptibility_to | 0.47360685 |
| 67 | MP0005266_abnormal_metabolism | 0.47120889 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.45329130 |
| 69 | MP0003879_abnormal_hair_cell | 0.45201428 |
| 70 | MP0002282_abnormal_trachea_morphology | 0.42861124 |
| 71 | MP0005334_abnormal_fat_pad | 0.41968431 |
| 72 | MP0004043_abnormal_pH_regulation | 0.39471820 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.38374465 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.36403726 |
| 75 | MP0004883_abnormal_blood_vessel | 0.35784047 |
| 76 | MP0005410_abnormal_fertilization | 0.34763668 |
| 77 | MP0009115_abnormal_fat_cell | 0.34667160 |
| 78 | MP0002419_abnormal_innate_immunity | 0.33965267 |
| 79 | MP0003959_abnormal_lean_body | 0.31893242 |
| 80 | MP0004036_abnormal_muscle_relaxation | 0.31890317 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.31269946 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.30991257 |
| 83 | MP0003953_abnormal_hormone_level | 0.30745816 |
| 84 | MP0004084_abnormal_cardiac_muscle | 0.29214327 |
| 85 | MP0003633_abnormal_nervous_system | 0.29159408 |
| 86 | MP0008873_increased_physiological_sensi | 0.28728693 |
| 87 | MP0005670_abnormal_white_adipose | 0.28673350 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.28659935 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.28359045 |
| 90 | MP0004215_abnormal_myocardial_fiber | 0.28320090 |
| 91 | MP0005025_abnormal_response_to | 0.27516199 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.26787936 |
| 93 | MP0005330_cardiomyopathy | 0.26769671 |
| 94 | MP0003436_decreased_susceptibility_to | 0.24106954 |
| 95 | MP0004130_abnormal_muscle_cell | 0.24023708 |
| 96 | MP0003631_nervous_system_phenotype | 0.23560749 |
| 97 | MP0002970_abnormal_white_adipose | 0.23036904 |
| 98 | MP0000920_abnormal_myelination | 0.22927556 |
| 99 | MP0005023_abnormal_wound_healing | 0.22692813 |
| 100 | MP0005448_abnormal_energy_balance | 0.21768898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.54913815 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.69646118 |
| 3 | Complement deficiency (HP:0004431) | 7.92824969 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.22737922 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.79323910 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 6.36607446 |
| 7 | Abnormality of complement system (HP:0005339) | 6.24236776 |
| 8 | Joint hemorrhage (HP:0005261) | 5.75225692 |
| 9 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.15962240 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.07049973 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.84304467 |
| 12 | Glomerulonephritis (HP:0000099) | 4.67992494 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45401470 |
| 14 | Spontaneous abortion (HP:0005268) | 4.41969633 |
| 15 | Xanthomatosis (HP:0000991) | 4.35388503 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.22025851 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.06911919 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 3.95673570 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.95520289 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.62503750 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.52939324 |
| 22 | Hyperammonemia (HP:0001987) | 3.47725698 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.43669541 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34903853 |
| 25 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.23887828 |
| 26 | Nephritis (HP:0000123) | 3.09769922 |
| 27 | Gingival bleeding (HP:0000225) | 3.04760369 |
| 28 | Purpura (HP:0000979) | 2.91777416 |
| 29 | Hyperglycinemia (HP:0002154) | 2.88727195 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.86815099 |
| 31 | Osteomalacia (HP:0002749) | 2.80280034 |
| 32 | Fat malabsorption (HP:0002630) | 2.79779394 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 2.75820495 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 2.68860892 |
| 35 | Delayed CNS myelination (HP:0002188) | 2.62454268 |
| 36 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.61886610 |
| 37 | Metabolic acidosis (HP:0001942) | 2.57693330 |
| 38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.55946530 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.55946530 |
| 40 | Pulmonary embolism (HP:0002204) | 2.55823794 |
| 41 | Abnormal gallbladder physiology (HP:0012438) | 2.54551136 |
| 42 | Cholecystitis (HP:0001082) | 2.54551136 |
| 43 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.53244422 |
| 44 | Absent/shortened dynein arms (HP:0200106) | 2.53244422 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.53086606 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.53086606 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.49887511 |
| 48 | Thrombophlebitis (HP:0004418) | 2.48375402 |
| 49 | Rhinitis (HP:0012384) | 2.46183466 |
| 50 | Epidermoid cyst (HP:0200040) | 2.45620193 |
| 51 | Arthropathy (HP:0003040) | 2.45522521 |
| 52 | Menorrhagia (HP:0000132) | 2.39966243 |
| 53 | Abnormality of iron homeostasis (HP:0011031) | 2.39085392 |
| 54 | Increased serum ferritin (HP:0003281) | 2.37816891 |
| 55 | Steatorrhea (HP:0002570) | 2.36980324 |
| 56 | Atrioventricular block (HP:0001678) | 2.36179215 |
| 57 | Bile duct proliferation (HP:0001408) | 2.34961979 |
| 58 | Abnormal biliary tract physiology (HP:0012439) | 2.34961979 |
| 59 | Abnormal ciliary motility (HP:0012262) | 2.34926913 |
| 60 | Vascular calcification (HP:0004934) | 2.27957436 |
| 61 | Gangrene (HP:0100758) | 2.24460156 |
| 62 | Hyperglycinuria (HP:0003108) | 2.23171469 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.20841818 |
| 64 | Rickets (HP:0002748) | 2.15172047 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.10432933 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 2.09721830 |
| 67 | Irritability (HP:0000737) | 2.08307306 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.07828375 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07769605 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.06822278 |
| 71 | Glycosuria (HP:0003076) | 2.03432065 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.03432065 |
| 73 | Deep venous thrombosis (HP:0002625) | 10.5418213 |
| 74 | Fair hair (HP:0002286) | 1.98795250 |
| 75 | Cardiovascular calcification (HP:0011915) | 1.95665875 |
| 76 | Ketosis (HP:0001946) | 1.93275886 |
| 77 | Alkalosis (HP:0001948) | 1.93264687 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92068963 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91210835 |
| 80 | Hyperbilirubinemia (HP:0002904) | 1.90339329 |
| 81 | Mitral stenosis (HP:0001718) | 1.90124267 |
| 82 | Chronic bronchitis (HP:0004469) | 1.86406018 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 1.83099608 |
| 84 | Hypercholesterolemia (HP:0003124) | 1.79055456 |
| 85 | Lethargy (HP:0001254) | 1.78292236 |
| 86 | Myocardial infarction (HP:0001658) | 1.77402973 |
| 87 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74804868 |
| 88 | Increased serum pyruvate (HP:0003542) | 1.74704989 |
| 89 | Retinal atrophy (HP:0001105) | 1.73287997 |
| 90 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73161822 |
| 91 | Vomiting (HP:0002013) | 1.73135469 |
| 92 | Abnormal pupillary function (HP:0007686) | 1.72513276 |
| 93 | Cerebral edema (HP:0002181) | 1.70177142 |
| 94 | Pancreatitis (HP:0001733) | 1.70130575 |
| 95 | Proximal tubulopathy (HP:0000114) | 1.67613235 |
| 96 | Cholelithiasis (HP:0001081) | 1.67507531 |
| 97 | Abnormality of purine metabolism (HP:0004352) | 1.65755529 |
| 98 | Joint swelling (HP:0001386) | 1.64611729 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 1.63329794 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 1.61980160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.17700495 |
| 2 | ERN1 | 3.84529927 |
| 3 | PIK3CG | 2.72948447 |
| 4 | ACVR1B | 2.70763528 |
| 5 | FGFR4 | 2.58202720 |
| 6 | TBK1 | 2.51490162 |
| 7 | BCKDK | 2.40301622 |
| 8 | MUSK | 2.13339391 |
| 9 | MAPKAPK3 | 2.00730344 |
| 10 | NEK9 | 1.93401944 |
| 11 | PRKACG | 1.91457915 |
| 12 | PINK1 | 1.90372786 |
| 13 | TYK2 | 1.87826427 |
| 14 | MAP3K3 | 1.83784032 |
| 15 | BLK | 1.81902086 |
| 16 | MAP3K12 | 1.81304474 |
| 17 | CAMKK2 | 1.77426237 |
| 18 | TIE1 | 1.74021606 |
| 19 | PDK2 | 1.72860003 |
| 20 | MYLK | 1.63083372 |
| 21 | PRKAA2 | 1.56454080 |
| 22 | GRK1 | 1.55096946 |
| 23 | PIK3CA | 1.51560345 |
| 24 | TAOK3 | 1.44401265 |
| 25 | ABL2 | 1.43506033 |
| 26 | PRKCG | 1.41927902 |
| 27 | IRAK3 | 1.41311442 |
| 28 | ADRBK2 | 1.38588068 |
| 29 | EPHA3 | 1.34430406 |
| 30 | MAP3K5 | 1.18618094 |
| 31 | PKN2 | 1.17952385 |
| 32 | PRKG1 | 1.15354152 |
| 33 | FRK | 1.13489296 |
| 34 | FGFR3 | 1.10441727 |
| 35 | ZAP70 | 1.10057961 |
| 36 | RIPK1 | 1.07609532 |
| 37 | PDPK1 | 1.06674398 |
| 38 | CDC42BPA | 1.05394494 |
| 39 | WNK3 | 1.05211061 |
| 40 | INSRR | 1.04222044 |
| 41 | FLT3 | 1.03886343 |
| 42 | PRKACA | 1.03572112 |
| 43 | PRKCE | 1.01574441 |
| 44 | MAP2K4 | 1.01248186 |
| 45 | MAP2K3 | 0.95111179 |
| 46 | CAMKK1 | 0.90848736 |
| 47 | IGF1R | 0.90400735 |
| 48 | MST4 | 0.79336708 |
| 49 | PRKCA | 0.77969191 |
| 50 | MAP4K2 | 0.76534046 |
| 51 | SGK1 | 0.74339079 |
| 52 | GRK6 | 0.74220213 |
| 53 | MAP3K6 | 0.69921094 |
| 54 | BMPR2 | 0.69009332 |
| 55 | PRKCZ | 0.68966256 |
| 56 | JAK1 | 0.68946033 |
| 57 | MAPK11 | 0.68644784 |
| 58 | SCYL2 | 0.67563830 |
| 59 | PDK1 | 0.66060608 |
| 60 | MAP3K2 | 0.65051574 |
| 61 | EPHA4 | 0.64726125 |
| 62 | PRKACB | 0.62679018 |
| 63 | DAPK3 | 0.62136537 |
| 64 | STK38L | 0.61746247 |
| 65 | NTRK3 | 0.61456101 |
| 66 | MST1R | 0.60352245 |
| 67 | PIM2 | 0.60016084 |
| 68 | TNK2 | 0.59977178 |
| 69 | CSNK1D | 0.59520958 |
| 70 | TGFBR2 | 0.59375113 |
| 71 | PRKCB | 0.59364153 |
| 72 | MAPK12 | 0.57627262 |
| 73 | STK38 | 0.57334525 |
| 74 | ERBB2 | 0.56735683 |
| 75 | RPS6KA3 | 0.55563741 |
| 76 | TRPM7 | 0.55425311 |
| 77 | CAMK2G | 0.54765532 |
| 78 | EIF2AK3 | 0.54758038 |
| 79 | TAOK2 | 0.53784833 |
| 80 | PRKAA1 | 0.53046637 |
| 81 | ARAF | 0.52620776 |
| 82 | BRSK2 | 0.51919889 |
| 83 | IKBKB | 0.50549476 |
| 84 | ERBB4 | 0.49109869 |
| 85 | JAK2 | 0.47982077 |
| 86 | CSK | 0.46596611 |
| 87 | MAPK4 | 0.46452689 |
| 88 | STK16 | 0.45907627 |
| 89 | MAP3K7 | 0.45428134 |
| 90 | EPHB1 | 0.44222845 |
| 91 | MET | 0.43668031 |
| 92 | FER | 0.43341647 |
| 93 | CSNK2A2 | 0.42653247 |
| 94 | OBSCN | 0.42469111 |
| 95 | JAK3 | 0.41333600 |
| 96 | MAP2K6 | 0.41178880 |
| 97 | EIF2AK1 | 0.39148603 |
| 98 | IKBKE | 0.38727210 |
| 99 | TAOK1 | 0.38294588 |
| 100 | PRKD1 | 0.37805219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.66558451 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.28641207 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.38421382 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26552439 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06675136 |
| 6 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.01606477 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.95064096 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.90437705 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.89341147 |
| 10 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.88633992 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.87920097 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85193889 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79962042 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.67526343 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43913147 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.26452973 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.10948604 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03021909 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96112272 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.85714447 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.77726861 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.77462602 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63865399 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62833578 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61805600 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.59099868 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49119276 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48173175 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46811265 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43268847 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40915578 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35037385 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30646762 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30422990 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27544481 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26333518 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23522268 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22015420 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19741247 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15582227 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15057205 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12726694 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.06643980 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04078580 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03206199 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88390188 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87177850 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86316375 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83772781 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78866573 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76793202 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70658050 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63291440 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61959909 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61267924 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59218377 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.58514445 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57989708 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52406179 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50217426 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49746282 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48128080 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.41520065 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40057039 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34478739 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34076859 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.33886458 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32628705 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26031964 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24946397 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23942501 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.19580909 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.15050267 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11512973 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07985427 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07914546 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07439883 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06709363 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.05030436 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.04327604 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04155847 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04136234 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02318900 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.01671659 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01477404 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01100817 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1755607 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1746966 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1709462 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1507224 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1222536 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1180902 |
| 93 | Lysosome_Homo sapiens_hsa04142 | -0.1092260 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0988513 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0928243 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0539228 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0397381 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0250460 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0189332 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0012818 |

